PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of mardrugsMDPIHomeThis articleThis journalInstructions for authorsSubscribemarine drugs
 
Mar Drugs. 2010; 8(5): 1650–1680.
Published online 2010 May 10. doi:  10.3390/md8051650
PMCID: PMC2885083

On the Chemistry, Toxicology and Genetics of the Cyanobacterial Toxins, Microcystin, Nodularin, Saxitoxin and Cylindrospermopsin

Abstract

The cyanobacteria or “blue-green algae”, as they are commonly termed, comprise a diverse group of oxygenic photosynthetic bacteria that inhabit a wide range of aquatic and terrestrial environments, and display incredible morphological diversity. Many aquatic, bloom-forming species of cyanobacteria are capable of producing biologically active secondary metabolites, which are highly toxic to humans and other animals. From a toxicological viewpoint, the cyanotoxins span four major classes: the neurotoxins, hepatotoxins, cytotoxins, and dermatoxins (irritant toxins). However, structurally they are quite diverse. Over the past decade, the biosynthesis pathways of the four major cyanotoxins: microcystin, nodularin, saxitoxin and cylindrospermopsin, have been genetically and biochemically elucidated. This review provides an overview of these biosynthesis pathways and additionally summarizes the chemistry and toxicology of these remarkable secondary metabolites.

Keywords: cyanotoxin, non-ribosomal peptide, polyketide, alkaloid, toxicology

1. Microcystin

1.1. Introduction

The heptapeptide hepatotoxin, microcystin, has been isolated from multiple genera of cyanobacteria, including Microcystis, Anabaena, Oscillatoria, Planktothrix, Chroococcus and Nostoc. Microcystin-producing strains such as Microcystis aeruginosa have a cosmopolitan distribution and thrive in a range of climates, making these organisms a global threat to human health. Consequently, significant research efforts have been directed towards their identification and eradication.

1.2. Chemistry

The microcystins comprise the largest and most structurally diverse group of cyanobacterial toxins. Around 90 microcystin isoforms varying by degree of methylation, hydroxylation, epimerization, peptide sequence and toxicity have been identified [1,2]. Underlying the extraordinary heterogeneity present among the microcystins is their common cyclic structure (Figure 1) and possession of several rare, highly conserved amino acid moieties. Collectively, the microcystins may be described as monocyclic heptapeptides containing both d-and l-amino acids plus N-methyldehydroalanine and a unique ß-amino acid side-group, 3-amino-9-methoxy-2-6,8-trymethyl-10-phenyldeca-4,6-dienoic acid (Adda) [3]. The microcystin isoforms differ primarily at the two l-amino acids, and secondarily on the presence or absence of the methyl groups on d-erythro-β-methylaspartic acid (d-MeAsp) and/or N-methyldehydroalanine (Mdha) [4]. However, substitutions of all moieties within microcystin have been reported [57].

Figure 1
Structure of microcystin. General numbering of residues is indicated. Microcystin is a cyclic heptapeptide. The two variable amino acids in microcystin are indicated by X and Y. The most common isoform is microcystin-LR (MW 995.17), where X is l-Leu and ...

1.3. Toxicology

Acute cases of microcystin poisoning may cause rapid death in humans and other animals [8]. Upon ingestion, microcystin is transported to the liver by organic anion transport proteins where they exert their toxicity via inhibition of protein phosphatases 1 and 2A [911]. Inhibition of protein phosphatases can lead to excessive phosphorylation of structural filaments, subsequent cyto-skeletal degradation and breakdown of hepatic ultra structure [12,13]. Retraction of hepatocytes from neighboring cells and sinusoidal capillaries causes blood to become pooled in the liver tissues. This ultimately results in local tissue damage, organ failure and haemorrhagic shock [13].

Varying levels of toxicity have been reported for each microcystin isoform. For example, the LD50 of the most common isoform, microcystin-LR, is 50 μg per kilogram of body weight in mice [14], while the rarer microcystin-RR requires a significantly higher dose of 600 μg to produce the same lethal effect [15].

The revelation that cyanobacterial hepatotoxins cause protein phosphatase inhibition has raised the disturbing possibility that human exposure to non-lethal doses of these compounds may contribute to the development of cancer [16,17]. Several laboratory studies have indicated that chronic exposure to microcystin can indeed promote skin and liver tumors in rats and mice [18,19]. Epidemiological data suggest that similar long-term effects such as hepatocellular carcinoma may also be observed in humans [20,21]. Such results highlight the need for sensitive and rapid detection methods and stringent monitoring of cyanobacterial hepatotoxins in drinking water supplies.

1.4. Biosynthesis and Genetics

Microcystin is synthesized non-ribosomally by the thiotemplate function of a large multifunctional enzyme complex containing both non-ribosomal peptide synthetase (NRPS) and polyketide synthase (PKS) domains. The gene cluster encoding these biosynthetic enzymes, mcyS, has been sequenced and partially characterized in several cyanobacterial species including Microcystis, Anabaena, and Planktothrix [2224] (Figure 2). Such fundamental studies have offered insight into the evolution of cyanotoxin biosynthesis, and have additionally provided much of the groundwork for current PCR-based cyanobacterial detection methods.

Figure 2
Hepatotoxin gene clusters from various cyanobacteria. Structures of the microcystin and nodularin gene clusters of (A) N. spumigena, (B) M. aeruginosa, (C) P. agardhii, and (D) Anabaena sp. 90, showing genes encoding polyketide synthases (white), non-ribosomal ...

The microcystin biosynthesis gene cluster, mcyS, was the first complex metabolite gene cluster to be fully sequenced from a cyanobacterium. In M. aeruginosa PCC7806, the mcyS gene cluster spans 55 kb and comprises 10 genes arranged in two divergently transcribed operons, mcyA–C and mcyD–J. The larger of the two operons, mcyD–J, encodes a modular PKS (McyD), two hybrid enzymes comprising NRPS and PKS modules (McyE and McyG), and enzymes putatively involved in the tailoring (McyJ, F, and I) and transport (McyH) of the toxin. The smaller operon, mcyA–C encodes three NRPSs (McyAC) [22].

The formation of Adda putatively involves enzymes encoded by mcyD–G and J, based on bioinformatic analyses and homology to related enzymes (Figure 3a). The hybrid NRPS/PKS enzyme, McyG, constitutes the first step in Adda biosynthesis. It was initially hypothesized that the NRPS module of McyG activates phenylacetate, however, recent biochemical characterization of the McyG A–PCP didomain has revealed that assorted phenylpropanoids are preferentially activated and loaded onto the PCP [25]. Following activation, the phenylpropanoid starter unit is extended by several malonyl-CoA elongation steps and subsequently modified by C-methylation, reduction and dehydration, all catalyzed by the PKS modules of McyD, E and G. The aminotransferase domain of McyE then converts the polyketide to a β-amino acid in the final step of Adda biosynthesis. The NRPS module of the second hybrid PKS/NRPS enzyme, McyE, is thought to be involved in the activation and condensation of d-Glu with Adda.

Figure 3
(uper) Model for the formation of Adda during microcystin biosynthesis and predicted domain structure of McyG, McyD and McyE. (lower) Biosynthetic model for microcystin-LR and predicted domain structure of McyE, McyA, McyB, and McyC. Each circle and rectangle ...

The mcyF ORF was originally predicted to encode a glutamate racemase, responsible for the epimerization of the l-Glu residue of microcystin [22,26]. A subsequent study by [27] contended this theory and offers evidence that McyF acts exclusively as an Asp racemase. The authors propose that the d-Glu residue is provided by an l-Glu racemase residing outside the mcyS gene cluster. Mutagenesis experiments in P. agardhii showed that the production of Adda also involves an O-methylation step catalyzed by the putative monofunctional tailoring enzyme, McyJ [23].

The remaining biosynthetic enzymes in the microcystin biosynthesis pathway (NRPSs) are putatively involved in the specific activation, modification and condensation of substrate amino acids onto the linear peptide chain, which is then cyclized to produce microcystin. Firstly, McyA adds l-Ser to the growing chain, followed by the addition of d-Ala. This step is followed by the addition of l-Leu and d-MeAsp residues (McyB) followed by the addition of l-Arg (McyC), and subsequent cyclization and release of the final peptide product (Figure 3b).

The remaining stand alone enzyme, the 2-hydroxy-acid dehydrogenase, McyI, is putatively involved in the production of d-methylaspartate at position three within the microcystin cyclic structure via the conversion of 3-methylmalate to 3-methyloxalacetate. It is hypothesized that a promiscuous aspartate aminotransferase then converts 3-methyloxalacetate to methylaspartate [28].

An ABC transporter gene, mcyH, is believed to be involved in the transport of microcystin [29]. This transporter may be responsible for the thylakoid localization of the toxin [30,31] or for the extrusion of the toxin under certain growth conditions, including exposure to high and red light [32].

Comparative studies of the mcyS gene clusters from M. aeruginosa, P. agardhii [23], and Anabaena sp. [24] have noted variation in the arrangement of mcyS genes between these different species of cyanobacteria, although the proposed toxin biosynthetic processes are thought to be similar. The M. aeruginosa and Anabaena sp. mcyS clusters are both arranged into two divergently transcribed operons, however, the arrangement of genes within these operons differs between the two species (Figure 2). In P. agardhii, the mcyS cluster also has a distinctive arrangement and lacks mcyF and mcyI. Furthermore, the P. agardhii mcyS cluster contains an additional gene mcyT, upstream of the central promoter region. This gene is thought to encode a putative type II thioesterase enzyme, which may play an editing role by removing mis-primed amino acids from the NRPS and PKS enzymes. The characterization of mcyS in M. aeruginosa, P. agardhii and Anabaena sp. has important implications for understanding the origins and evolution of hepatotoxin biosynthesis in cyanobacteria. The identification of transposases associated with the mcyS and ndaS (nodularin) gene clusters and subsequent phylogenetic analysis has led to the theory that horizontal gene transfer and recombination events are responsible for the sporadic distribution of the mcyS gene cluster throughout the cyanobacteria and the various microcystin isoforms that have been identified to date [22,33,34].

Hepatotoxin production in cyanobacteria is thought to be influenced by a number of different physical and environmental parameters, including nitrogen, phosphorous, trace metals, growth temperature, light, and pH [3541]. However, due to the fact that most regulatory investigations have not been standardized, and the data have not been interpreted against the same specific growth controls, the subject of hepatotoxin regulation remains a somewhat contentious issue. While most toxin regulation studies have focused on direct measurements of cellular toxin, the description of the mcy gene cluster by Tillett and co-workers [22] enabled a closer examination of microcystin regulation at the molecular level [32]. Kaebernick et al. used the RNase protection assay to measure the transcription of mcyB and mcyD under a variety of different light conditions. High light intensities and red light were correlated with increased transcription, while blue light led to reduced transcript levels. Interestingly, the authors observed two light thresholds, between dark and low light (0 and 16 μmol photons m-2 s-1), and medium and high light (31 and 68 μmol photons m-2 s-1), at which a significant increase in transcription occurred. The same group later found that transcription of mcy genes occurs via two polycistronic operons, mcyABC and mcyDEFGHIJ, from a central bidirectional promoter between mcyA and mcyD [42]. Interestingly, alternate transcriptional start sites were identified for both operons when cells were cultured under different light intensities. For example, under low light conditions, the polyketide and tailoring genes mcyD–J are transcribed as part of a polycistronic message (mcyDEFGHIJ) from a central (mcyD) promoter, while under high light conditions, the genes are transcribed from an alternative up-stream promoter. It is thought that initiation from the alternate promoters under high light conditions may lead to increased transcription, as previously observed for mcyB and mcyD. Many of the tailoring enzymes (mcyF, G, H, I and J) also possess their own individual promoters [32].

Interestingly, light intensity also appears to favor the production of certain microcystin variants over others. For example, Tonk et al. (2005) found that the cellular content of total microcystin remained constant, independent of the irradiance. However, of the two main microcystin variants detected in P. agardhii, the microcystin-DeRR content decreased two-fold with increased photon irradiance, whereas the microcystin-DeLR content increased three-fold. Since microcystin-DeLR is considerably more toxic than microcystin-DeRR, this implies that P. agardhii becomes more toxic at high light intensities [40].

Other factors such as nutrient content and temperature have also been demonstrated to affect mcyS expression and toxin biosynthesis. For example, Sevilla et al. (2008) investigated the effect of iron on mcyS expression and toxin biosynthesis in M. aeruginosa PCC7806 [41]. Real-time PCR analysis and HPLC were used to measure transcription of mcyD and the synthesis of microcystin-LR, respectively. The results of this study suggested that iron starvation causes an increase in mcyD transcription, correlative to the increase of toxin levels [41]. Davis et al. (2009) investigated the effects of temperature on Microcystis growth and toxin genes and found that elevated temperatures yield more toxic Microcystis cells and/or cells with more mcyD copies per cell, with either scenario potentially yielding more toxic blooms [39].

2. Nodularin

2.1. Introduction

The cyclic pentapeptide nodularin is most commonly isolated from the filamentous, planktonic cyanobacterium, Nodularia spumigena. This species generally forms toxic blooms in brackish and estuarine environments. Blooms of toxic N. spumigena occur annually during summer months in the Baltic Sea [43] resulting in nodularin being one of the most abundant naturally occurring compounds in the Baltic Sea. Blooms are also particularly common within the estuaries and coastal lagoons of Australia [44,45], and have been reported worldwide, including on the German North Sea coast [46], New Zealand [47], and North America [48]. N. spumigena scums have also been reported in the fresh to brackish/saline lakes at the mouth of the lower River Murray, South Australia, which is a major source of both potable and irrigation water [49]. Nodularin is structurally similar to microcystin and can induce similar toxic effects. The toxin has been reported to have detrimental effects on numerous organisms within the ecosystem, including invertebrates and fish, but may have no effect on other organisms [50].

The consumption of water containing toxic N. spumigena blooms has led to the death of domestic and native animals by massive liver haemorrhage [46,47,51,52]. In sub-acute doses, nodularin, like microcystin, is thought to act as a liver tumor initiator and promoter [53]. N. spumigena blooms are also of importance to the seafood industry. Nodularin has been shown to accumulate in shellfish and other seafood. Surveys of mussels, prawns, flounder both in Australia and the Baltic Sea report that nodularin accumulated to levels of concern with the potential to cause hepatotoxicity [5456].

2.2. Chemistry

Nodularin is a cyclic pentapeptide with a similar structure to microcystin, consisting of Adda, d-glutamic acid (d-Glu), N-methyldehydrobutyrine (MeDhb), d-erythro-β-methylaspartic acid (d-MeAsp), and l-arginine (l-Arg) (Figure 4) [57].

Figure 4
Structure of nodularin. General numbering of residues is indicated. Nodularin is a cyclic pentapeptide (MW 619). The l-Arg residue of nodularin may be replaced with a homoarginine (nodularin-Har) or valine residue (motuporin).

Seven naturally-occurring isoforms of nodularin have been reported to date. Two of these isoforms, produced by a New Zealand Nodularia sp. bloom, have variations within the Adda residue, which reduces or abolishes the toxicity of the compound [5]. The d-Glu residue is essential for toxicity of nodularin, as esterification of its free carboxyl abolishes toxicity, however, substitution at position 1 has little effect on toxicity. The other two isoforms, nodularin-Har and motuporin, are variable at position 2. Nodularin-Har is produced by the strain N. harveyana PCC7804, with the l-Arg, replaced with l-Homoarginine (l-Har) [58,59]. Motuporin has been isolated from the Papua New Guinea sponge Theonella swinhoei, and may be synthesized by an associated cyanobacterium. The l-Arg residue of nodularin is replaced by l-Val in motuporin [60]. The l-Val residue is responsible for additional cytotoxicity of motuporin against cancer cell lines.

2.3. Toxicology

Nodularin is a potent hepatotoxin in humans and other animals. Nodularin induces liver hemorrhage in mice and has a lethal dose 50 (LD50) of 50 μg.kg-1 (intra-peritoneal route of injection) in mice [61]. At doses below this concentration, nodularin may act as a carcinogen via the initiation and promotion of liver cell division [53].

The hepatotoxicity and carcinogenicity of nodularin is associated with the inhibition of eukaryotic protein phosphatase (PP) catalytic subunit types 1 and 2A [62]. The toxin inhibits the activity of PP2A to a greater extent than PP1. Inhibition of PP2A by nodularin occurs at relatively the same concentration (IC50) as that of microcystin (~0.1 nM) [62]. The hydrophobic C20 β-amino acids Adda, present in both toxins, blocks PP enzyme activity by interacting with the hydrophobic groove and obstructing substrate access to the active site cleft [6365]. MeDhb binds to Cys273 of PP2A in a similar fashion to the MeDha residue in microcystin which binds to Cys273 of PP1 and Cys266 of PP2A [64,66], however, binding of the toxin does not occur covalently and may be the reason for its additional carcinogenic properties [67].

The toxic effects of nodularin are primarily associated with the hepatocytes due to active transport of the toxin to the liver via the bile acid multi-specific organic anion transporters [10]. To date, studies have been unable to identify the specific mechanism of transport.

Nodularin has been observed to accumulate on different trophic levels, in numerous organisms including waterfowl, fish, mysid shrimp, zooplankton and benthic organisms [68]. Mesozooplankton in particular seem to play a major role in nodularin transfer to planktivorous fish [68]. The toxin appears to cause oxidative stress in the tissues in which it accumulates. In the case of the flounder (platichthys flesus L.), this oxidative stress occurs in the liver by way of reduced GST and CAT activities [69]. However, recent studies suggest that the toxin is rapidly detoxified and broken down or excreted [70].

2.4. Biosynthesis and Genetics

The nodularin biosynthesis gene cluster ndaS, from Nodularia spumigena NSOR10, was sequenced and characterized in 2004 by Moffitt and Neilan [71]. The 48 kb region of the genome consists of nine ORFs (ndaA-I) transcribed from a bidirectional regulatory promoter region (Figure 2). While most of the ndaS encoded genes have homologs in the mcyS cluster, their arrangement adheres more closely to the ‘co-linearity’ rule of NRPS pathways that predicts the order of catalytic processes involved in the biosynthesis of a non-ribosomal metabolite is generally the same as the order of the genes which encode their catalytic enzymes [72].

The proposed pathway for nodularin biosynthesis is similar to that for microcystin. Functional assignment of the enzymes was based on bioinformatic analysis and homology to the microcystin synthetase enzymes. The Adda side-chain is produced via a mixed NRPS/PKS pathway from a phenylacetate starter unit and several malonyl-CoA extensions (NdaC, D and F) (Figure 5). The NRPS module of the hybrid NRPS/PKS, NdaF, subsequently adds d-Glu to the growing chain. Two NRPS enzymes, NdaA and B, complete the cyclic pentapeptide by adding the final amino acid residues, l-Thr, d-MeAsp and l-Arg. The NRPS modules responsible for the activation of d-Ala and d-Leu in mcyS (McyA and B) are absent from ndaS as nodularin lacks these moieties. The NRPS and PKS proteins require posttranslational modification by a phosphopantetheinyl transferase (PPT) protein. The PPT required for activation of the Nda proteins is not clustered with the other nda genes. Recently, degenerate PCR and subsequent functional enzymatic characterization, identified the PPT required for nodularin biosynthesis in N. spumigena NSOR10 [73].

Figure 5
(uper). Model of the formation of Adda during nodularin biosynthesis and predicted domain structure of NdaC, D and F. (lower). Biosynthetic model for nodularin and predicted domain structure of NdaF, H, A and B. Each grey and green circle represents, ...

The ndaS cluster also encodes several putative monofunctional tailoring enzymes that may play a role in the modification and transport of nodularin. ndaE encodes an O-methyltransferrase, ndaG encodes a putative l-Asp/l-Glu racemase, and ndaI encodes an ABC transporter. Also encoded within the ndaS cluster is a d-3-PGDH homolog, NdaH, which shares 71% identity with McyI. It is likely therefore, that NdaH may be involved in the production of d-MeAsp [28].

Like mcyS, the ndaS gene cluster is transcriptionally regulated by a bi-directional promoter region. Analysis of transcription of the ndaS cluster found that it is transcribed as two polycistronic mRNA, ndaAB, ORF1, and ORF2, and ndaC [71]. The two genes downstream of ndaAB, ORF1 and ORF2, encode a putative transposase and a putative high light-inducible chlorophyll-binding protein, respectively. It is not clear why the putative transposase and the putative high light-inducible chlorophyll-binding protein are also co-transcribed with the ndaS gene cluster. ORF2 has been identified in all strains of toxic Nodularia and the association between ORF2 and nodularin biosynthesis may suggest a physiological function associated with high-light stress in the cells producing it. A putative heat shock repressor protein, encoded by the gene ORF3, was also identified downstream of ORF2, which may be involved in the transcriptional regulation of the ndaS genes in response to heat stress.

More recently, elucidation of the nda cluster has provided an opportunity to monitor transcriptional regulation of the biosynthetic pathway [74]. The effects of ammonia and phosphate starvation were analyzed. While expression of the nda cluster appears to be constitutive, phosphate starvation resulted in an approximately two-fold increase in expression, while ammonia supplementation decreased expression two-fold. Despite the changes to expression, intracellular and extracellular nodularin concentration remained stable [74].

3. Saxitoxin

3.1. Introduction

Saxitoxin and its analogs, collectively termed paralytic shellfish poisons (PSPs), are highly potent neurotoxins. Several freshwater species of cyanobacteria and marine dinoflagellates are known to produce saxitoxins. Blooms of these toxic species have led to mass kills of fish, native animals and livestock, as well as the contamination of freshwater resources [7577]. Saxitoxins typically accumulate through the food chain, in organisms consumed as seafood [78]. Marine shellfish are particularly resistant to the toxins, and can therefore accumulate dangerously high levels of PSPs by ingesting toxic plankton [79]. Saxitoxin and its analogs cause an annual estimated 2000 cases of PSP globally, with a mortality rate of 15% [80].

The capacity to synthesize saxitoxins and other PSPs has an unusually wide phylogenetic distribution, including both marine and freshwater organisms from two kingdoms of life (Eubacteria and Protista). Typically, there is little convergence between the structures of secondary metabolites from marine and freshwater organisms [81], or from organisms belonging to different phylogenetic groups. Although several studies suggest that other bacteria are capable of synthesizing PSPs [82,83], the findings are controversial, as the analytical methods used were not definitive and could not be readily repeated by other researchers [84]. On the other hand, PSP biosynthesis in cyanobacteria and dinoflagellates has been extensively verified and shown to be a consistent and heritable genetic trait [8590].

In the marine environment, dinoflagellate species capable of producing saxitoxins belong to the genera Alexandrium, Pyrodinium and Gymnodinium [9193]. While in freshwater systems, several filamentous species of cyanobacteria, such as Anabaena circinalis, Aphanizomenon sp., Aphanizomenon gracile, Cylindrospermopsis raciborskii and Lyngbya wollei are also known to produce saxitoxins [9497]. Saxitoxin production is varied among dinoflagellate and cyanobacterial producer genera, with not all species in a toxigenic genera being toxic, and different isolates of the same species having differential toxicity. Furthermore, cyanobacterial isolates of the same species from geographically distant locations provided different toxin profiles [89].

3.2. Chemistry

Saxitoxin is a trialkyl tetrahydropurine and the parent compound of more than 30 naturally occurring derivatives that differ structurally at four positions [98] (Figure 6.). The variable positions may be hydroxylated, sulfated or carbamoylated. Most of these analogs have been detected in both cyanobacteria and dinoflagellates [95,96,98101]. In addition to the usual carbamate and decarbamoyl toxins, six new saxitoxin derivatives have been isolated from the cyanobacteria Lyngbya wollei, including derivatives which provided an acetyl side-chain instead of the typical carbamate, or lacked one of the C-12 hydroxyl moieties [102]. Further unusual modifications, such as a C-11 ethanoic acid side-chain [103], or the N-hydroxylation of the carbamoyl side-chain [104], have also been described in xanthid crabs. In addition, the freshwater puffer fish was shown to produce a unique saxitoxin analog where the carbamoyl side-chain is N-methylated [105]. Furthermore, the Panamanian golden frog Atelopus zeteki produces zetekitoxin AB, which was recently confirmed to be a novel analog of saxitoxin, with sodium channel blocking activity 580-fold higher than that of saxitoxin [106]. Whether or not these complex eukaryotic organisms actually produce PSPs or simply accumulate the toxins in their tissues and organs is an issue of contention.

Figure 6
The core chemical structure of the paralytic shellfish poison (PSP), saxitoxin. ‘R’ represents variable positions. For a detailed list of isoforms see [98].

3.3. Toxicology

Saxitoxin and its derivatives are the causative agents of the common seafood poisoning, paralytic shellfish poisoning (PSP). PSP symptoms generally onset within 30 minutes of ingestion, and invariably begin with a tingling or burning of the lips, tongue and throat, increasing to total numbness of the face [98]. Further symptoms may include perspiration, vomiting and diarrhea. In cases of acute poisoning, numbness may spread to the neck and extremities and progress to muscular weakness, loss of motor coordination, and finally paralysis. A lethal dose of saxitoxin usually results in cardiovascular failure due to respiratory muscle paralysis [98]. There is no clinically approved antidote to saxitoxin poisoning, and treatments during early stages of PSP include removal of unabsorbed toxin with activated charcoal, and artificial respiration. The half-life of saxitoxin in the body is approximately 90 minutes, and survival chances increase significantly after 12 hours from initial exposure [107]. It is a highly potent blocker of voltage gated sodium channels present in neuronal cell membranes [108]. In addition, saxitoxin has also been shown to block calcium channels [109], and to prolong the gating of potassium channels in heart muscle cells [110]. Saxitoxin is a highly potent phycotoxin with an intraperitoneal LD50 of 10 μg/kg body weight in mice [111], while human death has occurred following the ingestion of as little as 1 mg of the toxin [112].

Mammals usually contain multiple isoforms of sodium channels, with different sensitivity to saxitoxin. This difference in sensitivity is due to variation in the amino acid sequence of the channel alpha subunit, whereby a single mutation may confer insensitivity to saxitoxin, though usually sacrificing speed of gating in the process [113]. The guanidinium groups and the carbon 12 hydroxyls in STX have been shown to be critical for the binding of the sodium channel, while the carbamoyl side chain also appears to be involved in the binding process, whereby one saxitoxin molecule binds one channel by lodging itself in the ion-conducting pore [113116].

The toxicity of saxitoxin derivatives varies greatly, with the carbamate toxins being 10–100-times more potent than the N-sulfo-carbamoyl derivatives [98,117]. N-sulfo-carbamoyl analogs are, however, labile and may easily be converted to the more toxic carbamate derivatives [118,119].

3.4. Biosynthesis and Genetics

Using a reverse genetic approach, Kellmann and co-workers [120] identified the gene cluster putatively responsible for the biosynthesis of saxitoxin in Cylindrospermopsis raciborskii T3 (sxt) (Figure 7c). The sxt gene cluster is encoded by more than 35 kb and comparative sequence analysis assigns 30 catalytic functions to 26 proteins. Bioinformatic analysis of this cyanobacterial saxitoxin gene cluster, coupled with identification of novel biosynthetic intermediates enabled a revision of the previously proposed saxitoxin biosynthesis pathway (Figure 8).

Figure 7
Structure of the paralytic shellfish toxin biosynthesis cluster (sxt) from; (a) Aphanizomenon sp. NH-5, (b) Anabaena circinalis AWQC131C, (c) Cylindrospermopsis raciborskii T3. Scale indicates gene length in kilobase pairs. Full bars and the letters A–E ...
Figure 8
Proposed saxitoxin biosynthetic pathway in cyanobacteria based on intermediate characterization and bioinformatic analysis. Dashed lines indicate possible alternative reactions [see text for detailed steps].

The first step in the revised saxitoxin biosynthesis pathway involves a Claisen condensation reaction catalyzed by SxtA. This unique enzyme possesses a polyketide synthase (PKS)-like structure composed of four catalytic domains, SxtA1-4: SxtA1 is homologous to SAM-dependant methyltransferases; SxtA2 is related to GCN5-related N-acetyl transferases (GNAT) that transfer acetate from acetyl-CoA to various heteroatoms [121]; SxtA3 is related to ACPs and also provides a phosphopantetheinyl-attachment site; SxtA4 is homologous to class II aminotransferases and is most similar to AONS (8-amino-7-oxononanoate synthase). The predicted reaction sequence of SxtA, based on its primary structure, is the loading of the ACP (SxtA3) with acetate from acetyl-CoA, followed by the SxtA1-catalyzed methylation of acetyl-ACP, converting it to propionyl-ACP. SxtA4, the class II aminotransferase domain, then performs a Claisen condensation reaction between propionyl-ACP and arginine. The putative product of SxtA is thus 4-amino-3-oxo-guanidinoheptane, which Kellmann et al. designated compound A.

The sxtG gene encodes a putative amidinotransferase, with highest amino acid sequence similarity to l-arginine/l-lysine amidinotransferases. SxtA is the putative substrate for SxtG, which transfers an amidino group from arginine to the α-amino A′ group, thus producing 4,7-diguanidino-3-oxoheptane (designated compound B′). SxtB, an enzyme similar to the cytidine deaminase-like enzymes from gammaproteobacteria, then catalyzes a retroaldol-like condensation in the conversion from B′ to C′.

The putative sterol desaturase, SxtD is predicted to introduce a double bond between C-1 and C-5 of C′, resulting in the 1,2-H shift between C-5 and C-6 (compound D′). The gene product of sxtS, which has sequence homology to nonheme iron 2-oxoglutarate-dependent dioxygenases, is predicted to perform the consecutive epoxidation of the new double bond and opening of the epoxide to an aldehyde with concomitant bicyclization. SxtU has sequence similarity to short-chain alcohol dehydrogenases and is therefore predicted to reduce the terminal aldehyde group of the saxitoxin precursor forming compound E′. The concerted action of SxtD, SxtS, and SxtU is therefore responsible for the hydroxylation and bicyclization of compound C′ to E′.

The gene product of sxtI is most similar to a predicted O-carbamoyltransferase from Trichodesmium erythraeum and other cyanobacteria. Kellmann et al.’s data [120] indicate that SxtI may catalyze the transfer of a carbamoyl group from carbamoylphosphate to the free hydroxy group of E′. Adjacent to sxtI are two short ORFs of unknown function, sxtJ and sxtK. While sxtJ and sxtK homologs are available in the databases, none of these genes have been functionally characterized.

sxtH and sxtT, each encode a terminal oxygenase subunit similar to those found in bacterial phenylpropionate and related ring-hydroxylating dioxygenases. SxtH and SxtT may therefore perform the consecutive hydroxylation of C-12, converting F′ into saxitoxin. Members belonging to bacterial phenylpropionate and related ring-hydroxylating dioxygenases are multicomponent enzymes, as they require an oxygenase reductase for their regeneration after each catalytic cycle. The sxt gene cluster provides a putative electron transport system, which would fulfill this function in the form of SxtV and SxtW. SxtV, a 4Fe-4S ferredoxin, could putatively extract an electron pair from succinate, converting it to fumarate [122]. SxtW a fumarate/reductase/succinate dehydrogenase homolog could then transfer the electrons via ferredoxin to SxtH and SxtT.

Following synthesis of the parent molecule saxitoxin, modifying enzymes introduce various functional groups. In addition to saxitoxin, C. raciborskii T3 produces N-1-hydroxylated (neoSTX), decarbamoylated (dcSTX), and N-sulfurylated (GTX-5) toxins, whereas Anabaena circinalis AWQC131C produces decarbamoylated (dcSTX) toxins and O-sulfurylated (GTX-3/GTX-2, dcGTX-3/dcGTX-2) toxins, as well as both O-and N-sulfurylated toxins (C-1/C-2), but no N-1-hydroxylated toxins [99].

sxtX encodes an enzyme with homology to cephalosporin hydroxylase. sxtX was detected only in C. raciborskii T3, Aphanizomenon flosaquae NH-5, and Lyngbya wollei, which produce N-1-hydroxylated analogs of saxitoxin [94,108,123], such as neoSTX. This component of the gene cluster was not present in any strain of A. circinalis, and therefore probably represents the reason why this species does not produce N-1-hydroxylated PSP toxins [89,99]. The predicted function of SxtX is therefore the N-1 hydroxylation of saxitoxin.

A. circinalis AWQC131C and C. raciborskii T3 also produce N-and O-sulfated analogs of saxitoxin [GTX-5, C-2/C-3, (dc)GTX-3/GTX-4]. The activity of two 3′-phosphate 5′-phosphosulfate (PAPS)-dependent sulfotransferases, which were specific for the N-21 of saxitoxin and GTX-3/GTX-2 and the O-22 of 11-hydroxy saxitoxin, respectively, has been described previously in studies of the PSP toxin-producing dinoflagellate Gymnodinium catenatum [124,125]. A putative sulfotransferase encoded by sxtN is predicted to transfer a sulfate group to either N-21 or O-22. Interestingly, the sxt gene cluster also encodes an adenylylsulfate kinase (APSK), SxtO, putatively involved in the formation of PAPS. Other biosynthetic gene clusters that result in sulfated secondary metabolites also contain genes required for the production of PAPS [126].

Decarbamoylated analogs of STX could be produced via either of two hypothetical scenarios. Enzymes that act downstream of SxtI, the carbamoyltransferase, in the biosynthesis of PSP toxins are proposed to exhibit broad substrate specificity, processing both carbamoylated and decarbamoylated precursors of STX. Alternatively, hydrolytic cleavage of the carbamoyl moiety from STX or its precursors may occur. SxtL is related to GDSL lipases, which are multifunctional enzymes with thioesterase, arylesterase, protease, and lysophospholipase activities [127]. The function of SxtL could therefore include the hydrolytic cleavage of the carbamoyl group from STX analogs.

Kinetic studies of PSP toxin accumulation in producing cells and the media of cyanobacterial cultures suggest that there is an active transport mechanism for these toxins [85]. In addition, variations in the concentration of sodium in culture media are known to affect the accumulation of PSP toxins in producer cells [128]. sxtF and sxtM encoded two proteins with high sequence similarity to sodium-driven multidrug and toxic compound extrusion (MATE) proteins of the NorM family. Members of the NorM family of MATE proteins are bacterial sodium-driven antiporters that export cationic substances [129]. All of the PSP toxins are cationic substances, except for the C toxins, which are zwitterionic. It is therefore probable that SxtF and SxtM are also involved in the export of PSP toxins.

Environmental factors such as nutrient (e.g., nitrogen and phosphate) content, salinity and temperature have been reported to regulate the production of PSP toxins in dinoflagellates and cyanobacteria [130132]. Two transcriptional factors, sxtY and sxtZ, related to PhoU and OmpR, respectively, as well as a two-component regulator histidine kinase proximal to the 3′ end of the sxt gene cluster in C. raciborskii T3 have been identified. PhoU-related proteins are negative regulators of phosphate uptake [133], whereas OmpR-like proteins are involved in the regulation of a variety of metabolisms, including nitrogen [134] and osmotic balance [135]. It is therefore likely that PSP toxin production in C. raciborskii T3 may be regulated at the transcriptional level in response to the availability of phosphate as well as other environmental factors.

Following the identification and characterisation of the sxt cluster from C. raciborskii, Mihali et al. [136] have described similar gene clusters from an Australian isolate of Anabaena circinalis and an American isolate of Aphanizomenon sp. (Figure 7b and a, respectively). These saxitoxin gene clusters are slightly smaller than the C. raciborskii, spanning approximately 28 kb. The topology of all three sxt clusters is also varied which suggests the occurrence of multiple transposition events throughout the evolution of saxitoxin biosynthesis in the cyanobacteria. Phylogenetic analysis of the sxt O-carbamoyltransferase gene across several saxitoxin producing species indicated that the most likely origin of the gene was an ancestral a-proteobacterium and that the entire set of genes required for saxitoxin biosynthesis probably spread by horizontal gene transfer [137].

4. Cylindrospermopsin

4.1. Introduction

The cyanobacterial alkaloid toxin, cylindrospermopsin, was first identified in 1979 when 148 people were hospitalized with symptoms of hepatoenteritis on Palm Island (Queensland, Australia). This outbreak was later linked to a bloom of Cylindrospermopsis raciborskii in a drinking water reservoir [138,139]. In addition to its impact on human health, cylindrospermopsin poisonings have been linked to the death of domestic animals [140].

Eight cyanobacterial species have thus far been identified as cylindrospermopsin producers; Cylindrospermopsis raciborskii, Aphanizomenon ovalisporum, Aphanizomenon flosaquae, Umezakia natans, Rhaphdiopsis curvata and Anabaena bergii, Anabaena lapponica, and Lygnbya wollei [141148]. The wide distribution of cylindrospermopsin producing species, coupled with the invasiveness of the chief toxin producer, C. raciborskii, presents a major problem for water management, on a global scale [149].

4.2. Chemistry

Cylindrospermopsin is a polyketide-derived alkaloid with a central functional guanidino moiety and a hydroxymethyluracil attached to the tricyclic carbon skeleton [150] (Figure 9). The natural occurrence of an epimer at the hydroxyl bridge, 7-epicylindrospermopsin [151], and a cylindrospermopsin variant lacking the hydroxyl group at C7, 7-deoxycylindrospermopsin, have also been reported [143].

Figure 9
The chemical structure of the NRPS and PKS derived alkaloid cylindrospermopsin. Natural variants containing an epimer at the hydroxyl bridge (C7) or lacking the hydroxyl altogether have also been reported [151].

4.3. Toxicology

Cylindrospermopsin is a highly biologically active alkaloid, interfering with several metabolic pathways. It has hepatotoxic, general cytotoxic [152154] and neurotoxic [155] effects and is considered a potential carcinogen [156]. The toxicity of cylindrospermopsin is mediated through the inhibition of glutathione, protein synthesis and cytochrome P450 [152154,157], with the uracil moiety as well as the hydroxyl at C7 being crucial for toxicity [158,151]. In mammals, cylindrospermopsin poisoning can cause liver, kidney, thymus and heart damage [159,160].

4.4. Biosynthesis and Genetics

The cylindrospermopsin biosynthesis (cyr) gene cluster from C. raciborskii AWT205 was recently sequenced [161] The cluster spans 43 kb and contains 15 ORFs, which encode all the functions required for the biosynthesis, regulation and export of the toxin (Figure 10). Biosynthesis is initiated via an amidinotransfer onto glycine followed by five polyketide extensions and subsequent reductions, rings are formed via Michael additions in a step-wise manner. The uracil ring is formed by a novel pyrimidine biosynthesis mechanism and tailoring reactions, including sulfation and hydroxylation that complete biosynthesis (Figure 11).

Figure 10
Structural organization of the cylindrospermopsin gene cluster from C. raciborskii AWT205. Scale indicates gene cluster in base pairs.
Figure 11
Proposed biosynthetic pathway for cylindrospermopsin (see text for detail).

The first step in formation of the carbon skeleton of cylindrospermopsin involves the synthesis of guanidinoacetate via the transamidination of glycine [162164]. An amidinotransferase encoded by cyrA, putatively transfers a guanidino group from arginine [163], to glycine thus forming guanidinoacetate. A mixed NRPS-PKS encoded by cyrB is thought to activate guanidinoacetate, which is then transferred via the swinging arm of the peptidyl carrier protein (PCP) to the KS domain. The AT domain of CyrB activates malonyl-CoA and attaches it to the ACP. This is followed by a condensation reaction between the activated guanidinoacetate and malonyl-CoA in the KS domain. The methyl transferase (MT) domain identified in CyrB is predicted to methylate C13. CyrB contains two reducing modules, KR and DH. Their concerted reaction reduces the keto group to a hydroxyl followed by elimination of H2O, resulting in a double bond between C13 and C14. A nucleophilic attack of the amidino group at N19 onto the newly formed double bond between C13 and C14 then putatively occurs via a ‘Michael addition’. The cyclization follows Baldwin’s rules for ring closure [165], resulting in the formation of the first ring in cylindrospermopsin. This reaction could be spontaneous and may not require enzymatic catalysis, as it is energetically favorable [165]. This is the first of three ring formations and is one of the principal differences between Mihali et al.’s [161] biosynthetic pathway and that previously proposed [163].

The third step in the biosynthesis of cylindrospermopsin involves cyrC, which encodes a PKS with KS, AT, KR, and ACP domains. The action of these domains results in the elongation of the growing chain by an acetate via activation of malonyl-CoA by the AT domain, its transfer to ACP and condensation at the KS domain with the product of CyrB. The elongated chain is bound to the ACP of CyrC and the KR domain reduces the keto group to a hydroxyl group on C12. Following the catalysis of enzyme CyrC is CyrD, a PKS. The action of this PKS module on the product of CyrC results in the addition of one acetate and the reduction of the keto group on C10 to a hydroxyl and dehydration to a double bond between C9 and C10. This double bond is the site of a nucleophilic attack by the amidino group N19 via another Michael addition that again follows Baldwin’s rules of ring closure [165], resulting in the formation of the second ring, the first six-membered ring made in cylindrospermopsin. The intermediate produced by CyrD is the substrate for CyrE (step 5 in Figure 1). A PKS, CyrE, catalyzes the addition of one acetate and the formation of a double bond between C7 and C8. This double bond is attacked by N18 via a Michael addition and the third cyclisation occurs, resulting in the second 6-member ring. The cyrF gene encodes the final PKS module -a minimal PKS containing only a KS, AT, and ACP. CyrF acts on the product of CyrE and elongates the chain by an acetate, leaving C4 and C6 unreduced. Step 7 in the pathway involves the formation of the uracil ring, a reaction that has been elusive so far and is required for the toxicity of the final cylindrospermopsin compound [151].

The cylindrospermopsin gene cluster encodes two enzymes CyrG and CyrH that are most similar to the enzyme family of amidohydrolases/ureases/dihydrotases, whose members catalyze the formation and cleavage of N-C bonds. Mihali and co-workers [161] propose that these enzymes transfer a second guanidino group from a donor molecule, such as arginine or urea, onto C6 and C4 of cylindrospermopsin resulting in the formation of the uracil ring. The first reaction consists of the formation of a covalent bond between the N of the guanidino donor and C6 of cylindrospermopsin followed by an elimination of H2O forming a double bond between C5 and C6. The second reaction catalyses the formation of a bond between the second N on the guanidino donor and C4 of cylindrospermopsin, co-committently with the breaking of the thioester bond between the acyl carrier protein of CyrF and cylindrospermopsin, causing the release of the molecule from the enzyme complex. The third reaction -if required -would catalyze the cleavage of the guanidino group from a donor molecule other than urea. The action of CyrG and CyrH in the formation of the uracil ring in cylindrospermopsin describes a novel biosynthesis pathway of a pyrimidine. Mihali and co-workers’ [161] genetic analysis shows that cyclization may happen stepwise, with successive ring formation of the appropriate intermediate as it is synthesized. This mechanism also explains the lack of a thioesterase or cyclization domain, which are usually associated with NRPS/PKS modules and catalyze the release and cyclization of the final product from the enzyme complex.

The sulfation of cylindrospermopsin at C12 is likely to be carried out by the action of a sulfotransferase. The cyrJ gene encodes a protein that is most similar to human 3′-phosphoadenylyl sulfate (PAPS) dependent sulfotransferases. Similar enzymes have recently been implicated in the sulfation of other cyanotoxins [120]. The cylindrospermopsin gene cluster also encodes an adenylsulfate kinase (ASK), namely CyrN. ASKs are enzymes that catalyse the formation of PAPS, which is the sulfate donor for sulfotransferases. Mihali and co-workers [161] propose that CyrJ sulfates cylindrospermopsin at C12 while CyrN creates the pool of PAPS required for this reaction. Screening of cylindrospermopsin producing and non-producing strains revealed that the sulfotransferase genes were only present in cylindrospermopsin producing strains, further affirming the involvement of this entire cluster in the biosynthesis of cylindrospermopsin. The cyrJ gene might therefore be a good candidate for a toxin probe, as it is more unique than NRPS and PKS genes and would presumably have less cross-reactivity with other gene clusters containing these genes, which are common in cyanobacteria. The final tailoring reaction is carried out by CyrI. CyrI putatively catalyzes the hydroxylation of C7, a residue that, along with the uracil ring, seems to confer much of the toxicity of cylindrospermopsin [158,166].

The cylindrospermopsin gene cluster contains an ORF denoted cyrK, the product of which is most similar to sodium ion driven multi-drug and toxic compound extrusion proteins (MATE) of the NorM family. CyrK is hypothesized to function as a transporter for cylindrospermopsin, based on this homology and its central location in the cluster.

Cylindrospermopsin production has been shown to be highest when fixed nitrogen is eliminated from the growth media [167]. Flanking the cylindrospermopsin gene cluster are “hyp” gene homologs involved in the maturation of hydrogenases. In the cyanobacterium Nostoc PCC73102 they are under the regulation of the global nitrogen regulator NtcA, that activates transcription of nitrogen assimilation genes [168,169]. It is plausible that the cylindrospermopsin gene cluster is under the same regulation, as it is located wholly within the “hyp” gene cluster in C. raciborskii AWT205, and no obvious promoter region in the cylindrospermopsin gene cluster could be identified. Finally, the cylindrospermopsin cluster also includes an ORF at its 3’-end designated CyrO. By homology, it encodes a hypothetical protein that appears to possess an ATP binding cassette, and is similar to WD repeat proteins, which have diverse regulatory and signal transduction roles. CyrO may also have a role in transcriptional regulation and DNA binding. It also shows homology to AAA family proteins that often perform chaperone-like functions and assist in the assembly, operation, or disassembly of protein complexes. Further insights into the role of CyrO are hindered due to low sequence homology with other proteins in databases.

References and Notes

1. Sivonen K, Jones G. Toxic Cyanobacteria in Water: A Guide to Their Public Health consequences, Monitoring and Management. Vol. 1. E and FN Spon; New York, NY, USA: 1999. pp. 40–111.
2. Welker M, von Dohren H. Cyanobacterial peptides -nature’s own combinatorial biosynthesis. FEMS Microbiol Rev. 2006;30:530–563. [PubMed]
3. Botes D, Wessels P, Kruger H, Runnegar M, Santikarn S, Smith R, Barna J, Williams D. Structural studies on cyanoginosins-LR, -YR, -YA, and -YM, peptide toxins from Microcystis aeruginosa. J Chem Soc. 1985;1:2747–2748.
4. Namikoshi M, Yuan M, Sivonen K, Carmichael WW, Rinehart KL, Rouhiainen L, Sun F, Brittain S, Otsuki A. Seven new microcystins possessing two l-glutamic acid units, isolated from Anabaena sp. strain 186. Chem Res Toxicol. 1998;11:143–149. [PubMed]
5. Rinehart K, Namikoshi N, Choi B. Structure and biosynthesis of toxins from blue-green algae (cyanobacteria) J App Phycol. 1994;6:159–176.
6. Sivonen K. Cyanobacterial toxins and toxin production. Phycologia. 1996;35:12–24.
7. Chorus I, Bartram J. A Guide to their Public Health Consequences, Monitoring and Management. E & FN Spon; London, UK: 1999. Toxic Cyanobacteria in Water.
8. Jochimsen EM, Carmichael WW, An JS, Cardo DM, Cookson ST, Holmes CE, Antunes MB, de Melo Filho DA, Lyra TM, Barreto VS, Azevedo SM, Jarvis WR. Liver failure and death after exposure to microcystins at a hemodialysis center in Brazil. N Engl J Med. 1998;338:873–878. [PubMed]
9. Runnegar MT, Gerdes RG, Falconer IR. The uptake of the cyanobacterial hepatotoxin microcystin by isolated rat hepatocytes. Toxicon. 1991;29:43–51. [PubMed]
10. Runnegar M, Berndt N, Kaplowitz N. Microcystin uptake and inhibition of protein phosphatases: effects of chemoprotectants and self-inhibition in relation to known hepatic transporters. Toxicol Appl Pharmacol. 1995;134:264–272. [PubMed]
11. Dawson RM. The toxicology of microcystins. Toxicon. 1998;36:953–962. [PubMed]
12. Eriksson JE, Toivola D, Meriluoto JA, Karaki H, Han YG, Hartshorne D. Hepatocyte deformation induced by cyanobacterial toxins reflects inhibition of protein phosphatases. Biochem Biophys Res Commun. 1990;173:1347–1353. [PubMed]
13. Sahin A, Tencalla FG, Dietrich DR, Mez K, Naegeli H. Enzymatic analysis of liver samples from rainbow trout for diagnosis of blue-green algae-induced toxicosis. Am J Vet Res. 1995;56:1110–1115. [PubMed]
14. Krishnamurthy T, Carmichael WW, Sarver EW. Toxic peptides from freshwater cyanobacteria (blue-green algae). I. Isolation, purification and characterization of peptides from Microcystis aeruginosa and Anabaena flosaquae. Toxicon. 1986;24:865–873. [PubMed]
15. Watanabe MF, Oishi S, Harda K, Matsuura K, Kawai H, Suzuki M. Toxins contained in Microcystis species of cyanobacteria (blue-green algae) Toxicon. 1988;26:1017–1025. [PubMed]
16. Yoshizawa S, Matsushima R, Watanabe MF, Harada K, Ichihara A, Carmichael WW, Fujiki H. Inhibition of protein phosphatases by microcystins and nodularin associated with hepatotoxicity. J Cancer Res Clin Oncol. 1990;116:609–614. [PubMed]
17. Nishiwaki S, Fujiki H, Suganuma M, Nishiwaki-Matsushima R, Sugimura T. Rapid purification of protein phosphatase 2A from mouse brain by microcystin-affinity chromatography. FEBS Lett. 1991;279:115–118. [PubMed]
18. Falconer IR. Tumor promotion and liver injury caused by oral consumption of cyanobacteria. Environ Toxicol Water Qual. 1991;6:177–184.
19. Nishiwaki-Matsushima R, Ohta T, Nishiwaki S, Suganuma M, Kohyama K, Ishikawa T, Carmichael WW, Fujiki H. Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR. J Cancer Res Clin Oncol. 1992;118:420–424. [PubMed]
20. Yu S. Primary prevention of hepatocellular carcinoma. J Gastroenterol Hepatol. 1995;10:674–682. [PubMed]
21. Yu S. Drinking Water and Primary Liver Cancer. China academic publishers; New York, NY, USA: 1989.
22. Tillett D, Dittmann E, Erhard M, von Dohren H, Borner T, Neilan BA. Structural organization of microcystin biosynthesis in Microcystis aeruginosa PCC7806: an integrated peptide-polyketide synthetase system. Chem Biol. 2000;7:753–764. [PubMed]
23. Christiansen G, Fastner J, Erhard M, Borner T, Dittmann E. Microcystin biosynthesis in planktothrix: genes, evolution, and manipulation. J Bacteriol. 2003;185:564–572. [PMC free article] [PubMed]
24. Rouhiainen L, Vakkilainen T, Siemer BL, Buikema W, Haselkorn R, Sivonen K. Genes coding for hepatotoxic heptapeptides (microcystins) in the cyanobacterium Anabaena strain 90. Appl Environ Microbiol. 2004;70:686–692. [PMC free article] [PubMed]
25. Hicks LM, Moffitt MC, Beer LL, Moore B, Kelleher NL. Structural characterisation of in vitro and in vivo intermediates on the loading module of microcystin synthetase. ACS Chem Biol. 2006;1:93–102. [PubMed]
26. Nishizawa T, Asayama M, Shirai M. Cyclic heptapeptide microcystin biosynthesis requires the glutamate racemase gene. Microbiology. 2001;147:1235–1241. [PubMed]
27. Sielaff H, Dittmann E, Tandeau De Marsac N, Bouchier C, Von Dohren H, Borner T, Schwecke T. The mcyF gene of the microcystin biosynthetic gene cluster from Microcystis aeruginosa encodes an aspartate racemase. Biochem J. 2003;373:909–916. [PubMed]
28. Pearson LA, Barrow KD, Neilan BA. Characterization of the 2-hydroxy-acid dehydrogenase McyI, encoded within the microcystin biosynthesis gene cluster of Microcystis aeruginosa PCC7806. J Biol Chem. 2007;282:4681–4692. [PubMed]
29. Pearson LA, Hisbergues M, Borner T, Dittmann E, Neilan BA. Inactivation of an ABC transporter gene, mcyH, results in loss of microcystin production in the cyanobacterium Microcystis aeruginosa PCC 7806. Appl Environ Microbiol. 2004;70:6370–6378. [PMC free article] [PubMed]
30. Shi L, Carmichael WW, Miller I. Immuno-gold localization of hepatotoxins in cyanobacterial cells. Arch Microbiol. 1995;163:7–15. [PubMed]
31. Young FM, Thomson C, Metcalf JS, Lucocq JM, Codd GA. Immunogold localisation of microcystins in cryosectioned cells of Microcystis. J Struct Biol. 2005;151:208–214. [PubMed]
32. Kaebernick M, Neilan BA, Borner T, Dittmann E. Light and the transcriptional response of the microcystin biosynthesis gene cluster. Appl Environ Microbiol. 2000;66:3387–3392. [PMC free article] [PubMed]
33. Mikalsen B, Boison G, Skulberg OM, Fastner J, Davies W, Gabrielsen TM, Rudi K, Jakobsen KS. Natural variation in the microcystin synthetase operon mcyABC and impact on microcystin production in Microcystis strains. J Bacteriol. 2003;185:2774–2785. [PMC free article] [PubMed]
34. Tooming-Klunderud A, Mikalsen B, Kristensen T, Jakobsen KS. The mosaic structure of the mcyABC operon in Microcystis. Microbiology. 2008;154:1886–1899. [PubMed]
35. Sivonen K. Effects of light, temperature, nitrate, orthophosphate, and bacteria on growth of and hepatotoxin production by Oscillatoria agardhii strains. Appl Environ Microbiol. 1990;56:2658–2666. [PMC free article] [PubMed]
36. Lukac M, Aegerter R. Influence of trace metals on growth and toxin production of Microcystis aeruginosa. Toxicon. 1993;31:293–305. [PubMed]
37. van der Westhuizen AJ, Eloff JN. Effect of temperature and light on the toxicity and growth of the blue-green alga Microcystis aeruginosa (UV-006) Planta. 1985;163:55–59. [PubMed]
38. Song L, Sano T, Li R, Watanabe M, Liu Y, Kaya K. Microcystin production of Microcystis viridis (cyanobacteria) under different culture conditions. Phycol Res. 1998;42:19.
39. Davis TW, Berry DL, Boyer GL, Gobler CJ. The effects of temperature and nutrients on the growth and dynamics of toxic and non-toxic strains of Microcystis during cyanobacteria blooms. Harmful Algae. 2009;8:715–725.
40. Tonk L, Visser PM, Christiansen G, Dittmann E, Snelder EO, Wiedner C, Mur LR, Huisman J. The microcystin composition of the cyanobacterium Planktothrix agardhii changes toward a more toxic variant with increasing light intensity. Appl Environ Microbiol. 2005;71:5177–5181. [PMC free article] [PubMed]
41. Sevilla E, Martin-Luna B, Vela L, Bes MT, Fillat MF, Peleato ML. Iron availability affects mcyD expression and microcystin-LR synthesis in Microcystis aeruginosa PCC7806. Environ Microbiol. 2008;10:2476–2483. [PubMed]
42. Kaebernick M, Dittmann E, Borner T, Neilan BA. Multiple alternate transcripts direct the biosynthesis of microcystin, a cyanobacterial nonribosomal peptide. Appl Environ Microbiol. 2002;68:449–455. [PMC free article] [PubMed]
43. Sivonen K, Kononen K, Carmichael WW, Dahlem AM, Rinehart KL, Kiviranta J, Niemela SI. Occurrence of the hepatotoxic cyanobacterium Nodularia spumigena in the Baltic Sea and structure of the toxin. Appl Environ Microbiol. 1989;55:1990–1995. [PMC free article] [PubMed]
44. Jones GJ, Blackburn SI, Parker NS. A toxic bloom of Nodularia spumigena mertens in Orielton Lagoon, Tasmania. Aust J Mar Freshwater Res. 1994;45:787–800.
45. Heresztyn T, Nicholson BC. Nodularin concentrations in Lakes Alexandrina and Albert, South Australia, during a bloom of the cyanobacterium (blue-green alga) Nodularia spumigena and degradation of the toxin. Environ Toxicol Water Qual. 1997;12:273–282.
46. Nehring S. Mortality of dogs associated with a mass development of Nodularia spumigena (Cyanophyceae) in a brackish lake at the German North Sea coast. J Plankton Res. 1993;15:867–872.
47. Carmichael WW, Eschedor JT, Patterson GM, Moore RE. Toxicity and partial structure of a hepatotoxic peptide produced by the cyanobacterium Nodularia spumigena Mertens emend. L575 from New Zealand. Appl Environ Microbiol. 1988;54:2257–2263. [PMC free article] [PubMed]
48. Galat DL, Verdin JP, Sims LL. Large-scale patterns of Nodularia spumigena blooms in Pyramid Lake, Nevada, determined from Landsat imagery: 1972–1986. Hydrobiologia. 1990;197:147–164.
49. Baker PD, Humpage AR. Toxicity associated with commonly occurring cyanobacteria in surface waters of the Murray-Darling Basin, Australia. Aust J Mar Freshwater Res. 1994;45:773–786.
50. Karjalainen M, Engstrom-Ost J, Korpinen S, Peltonen H, Paakkonen JP, Ronkkonen S, Suikkanen S, Viitasalo M. Ecosystem consequences of cyanobacteria in the northern Baltic Sea. Ambio. 2007;36:195–202. [PubMed]
51. Carmichael WW. The Toxins of Cyanobacteria. Sci Am. 1994:64–72.
52. Francis G. Poisonous Australian lake. Nature. 1878;18:11–12.
53. Ohta T, Sueoka E, Iida N, Komori A, Suganuma M, Nishiwaki R, Tatematsu M, Kim SJ, Carmichael WW, Fujiki H. Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver. Cancer Res. 1994;54:6402–6406. [PubMed]
54. Van Buynder PG, Oughtred T, Kirkby B, Phillips S, Eaglesham G, Thomas K, Burch M. Nodularin uptake by seafood during a cyanobacterial bloom. Environ Toxicol. 2001;16:468–471. [PubMed]
55. Falconer IR, Choice A, Hosja W. Toxicity of edible mussels Mytilus edulis growing naturally in an estuary during a water bloom of the blue-green alga Nodularia spumigena. Environ Toxicol Water Qual. 1992;7:119–123.
56. Mazur-Marzec H, Tyminska A, Szafranek J, Plinski M. Accumulation of nodularin in sediments, mussels, and fish from the Gulf of Gdansk, southern Baltic Sea. Environ Toxicol. 2007;22:101–111. [PubMed]
57. Rinehart KL, Harada K, Namikoshi M, Chen C, Harvis CA, Munro MHG, Blunt JW, Mulligan PE, Beasley VR, Dahlem AM, Carmicheal WW. Nodularin, microcystin, and the configuration of Adda. J Am Chem Soc. 1988;110:8557–8558.
58. Saito K, Konno A, Ishii H, Saito H, Nishida F, Abe T, Chen C. Nodularin-Har: a new nodularin from Nodularia. J Nat Prod. 2001;64:139–141. [PubMed]
59. Beattie KA, Kaya K, Codd GA. The cyanobacterium Nodularia PCC7804, of freshwater origin, produces [l-Har2]nodularin. Phytochemistry. 2000;54:57–61. [PubMed]
60. deSilva ED, Williams DE, Anderson RJ, Klix H, Holmes CFB, Allen TM. Motuporin, a potent protein phosphatase inhibitor isolated from the Papua New Guinea sponge Theonella swinhoei Gray. Tetrahedron Lett. 1992;33:1561–1564.
61. Eriksson JE, Meriluoto JA, Kujari HP, Osterlund K, Fagerlund K, Hallbom L. Preliminary characterization of a toxin isolated from the cyanobacterium Nodularia spumigena. Toxicon. 1988;26:161–166. [PubMed]
62. Honkanen RE, Dukelow M, Zwiller J, Moore RE, Khatra BS, Boynton AL. Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases. Mol Pharmacol. 1991;40:577–583. [PubMed]
63. An J, Carmichael WW. Use of a colorimetric protein phosphatase inhibition assay and enzyme linked immunosorbent assay for the study of microcystins and nodularins. Toxicon. 1994;32:1495–1507. [PubMed]
64. MacKintosh RW, Dalby KN, Campbell DG, Cohen PT, Cohen P, MacKintosh C. The cyanobacterial toxin microcystin binds covalently to cysteine-273 on protein phosphatase 1. FEBS Lett. 1995;371:236–240. [PubMed]
65. Kelker MS, Page R, Peti W. Crystal structures of protein phosphatase-1 bound to nodularin-R and tautomycin: a novel scaffold for structure-based drug design of serine/threonine phosphatase inhibitors. J Mol Biol. 2009;385:11–21. [PMC free article] [PubMed]
66. Runnegar M, Berndt N, Kong SM, Lee EY, Zhang L. In vivo and in vitro binding of microcystin to protein phosphatases 1 and 2A. Biochem Biophys Res Commun. 1995;216:162–169. [PubMed]
67. Bagu JR, Sykes BD, Craig MM, Holmes CF. A molecular basis for different interactions of marine toxins with protein phosphatase-1. Molecular models for bound motuporin, microcystins, okadaic acid, and calyculin A. J Biol Chem. 1997;272:5087–5097. [PubMed]
68. Karjalainen M, Pääkkönen J, Peltonen H, Sipiä V, Valtonen T, Viitasalo M. Nodularin concentrations in Baltic Sea zooplankton and fish during a cyanobacterial bloom. Mar Biol. 2008;155:483–491.
69. Persson K, Legrand C, Olsson T. Detection of nodularin in European flounder (Platichthys flesus) in the west coast of Sweden: Evidence of nodularin mediated oxidative stress. Harmful Algae. 2009;8:832–838.
70. Vuorinen PJ, Sipia VO, Karlsson K, Keinanen M, Furey A, Allis O, James K, Perttila U, Rimaila-Parnanen E, Meriluoto JA. Accumulation and effects of nodularin from a single and repeated oral doses of cyanobacterium Nodularia spumigena on flounder (Platichthys flesus L.) Arch Environ Contam Toxicol. 2009;57:164–173. [PubMed]
71. Moffitt MC, Neilan BA. Characterization of the nodularin synthetase gene cluster and proposed theory of the evolution of cyanobacterial hepatotoxins. Appl Environ Microbiol. 2004;70:6353–6362. [PMC free article] [PubMed]
72. Kleinkauf H, Von Dohren H. A nonribosomal system of peptide biosynthesis. Eur J Biochem. 1996;236:335–351. [PubMed]
73. Copp JN, Roberts AA, Marahiel MA, Neilan BA. Characterization of PPTNs, a cyanobacterial phosphopantetheinyl transferase from Nodularia spumigena NSOR10. J Bacteriol. 2007;189:3133–3139. [PMC free article] [PubMed]
74. Jonasson S, Vintila S, Sivonen K, El-Shehawy R. Expression of the nodularin synthetase genes in the Baltic Sea bloom-former cyanobacterium Nodularia spumigena strain AV1. FEMS Microbiol Ecol. 2008;65:31–39. [PubMed]
75. Negri AP, Jones GJ, Hindmarsh M. Sheep mortality associated with paralytic shellfish poisons from the cyanobacterium Anabaena circinalis. Toxicon. 1995;33:1321–1329. [PubMed]
76. Reyero M, Cacho E, Martínez A, Vázquez J, Marina A, Fraga S, Franco J. Evidence of saxitoxin derivatives as causative agents in the 1997 mass mortality of monk seals in the Cape Blanc Peninsula. Nat Toxins. 1999;7:311–315. [PubMed]
77. Sawyer PJ, Gentile JH, Sasner JJJ. Demonstration of a toxin from Aphanisomenon flosaquae (L.) Ralfs. Can J Microbiol. 1968;14:1199–1204. [PubMed]
78. Shumway SE. Phycotoxin-related shellfish poisoning: Bivalve molluscs are not the only vectors. Rev Fish Sci. 1995;3:1–31.
79. Shumway SE, Cucci TL, Yentsch CM, Newell RC, Gainey L. The effects of the toxic dinoflagellate, Protogonyaulax tamarensis, on the physiology and behavior of marine molluscs. J Shellfish Res. 1988;7:132–133.
80. Hallegraeff GM. Harmful algal blooms: A global overview. In: Hallegraeff GM, Anderson DM, Cembella AD, editors. Manual on Harmful Marine Microalgae. UNESCO; Paris, France: 1995. pp. 1–22.
81. Daly JW. Marine toxins and nonmarine toxins: convergence or symbiotic organisms? J Nat Prod. 2004;67:1211–1215. [PubMed]
82. Baker TR, Doucette GJ, Powell CL, Boyer GL, Plumley FG. GTX(4) imposters: characterization of fluorescent compounds synthesized by Pseudomonas stutzeri SF/PS and Pseudomonas/Alteromonas PTB-1, symbionts of saxitoxin-producing Alexandrium spp. Toxicon. 2003;41:339–347. [PubMed]
83. Kodoma M, Ogata T, Sakamoto S, Sato S, Honda T, Miwatani T. Production of paralytic shellfish toxins by a bacterium Moraxella sp. isolated from Protogonyaulax tamarensis. Toxicon. 1990;28:707–714. [PubMed]
84. Martins CA, Alvito P, Tavares MJ, Pereira P, Doucette G, Franca S. Reevaluation of production of paralytic shellfish toxin by bacteria associated with dinoflagellates of the Portuguese coast. Appl Environ Microbiol. 2003;69:5693–5698. [PMC free article] [PubMed]
85. Castro D, Vera D, Lagos N, Garcia C, Vasquez M. The effect of temperature on growth and production of paralytic shellfish poisoning toxins by the cyanobacterium Cylindrospermopsis raciborskii C10. Toxicon. 2004;44:483–489. [PubMed]
86. Negri A, Stirling D, Quilliam M, Blackburn S, Bolch C, Burton I, Eaglesham G, Thomas K, Walter J, Willis R. Three novel hydroxybenzoate saxitoxin analogues isolated from the dinoflagellate Gymnodinium catenatum. Chem Res Toxicol. 2003;16:1029–1033. [PubMed]
87. Sako Y, Kim CH, Ishida Y. Mendelian inheritance of paralytic shellfish poisoning toxin in the marine dinoflagellateAlexandrium. Biosci Biotechnol Biochem. 1992:56692–56694.
88. Sako Y, Naya N, Yoshida Y, Kim CH, Ushida A, Ishida Y. Studies on the stability and heredity of PSP toxin composition in the toxic dinoflagellateAlexandrium. In: Lassus P, Arzul G, Erard P, Gentien C, Marcaillou-Le Baut C, editors. Harmful Marine Algal Blooms. London-Paris-New York; Nantes, France: 1995. pp. 345–350.
89. Velzeboer RMA, Baker PD, Rositano J, Heresztyn T, Codd GA, Raggett SL. Geographical patterns of occurrence and composition of saxitoxins in the cyanobacterial genus Anabaena (Nostocales, Cyanophyta) in Australia. Phycologia. 2000;39:395–407.
90. Mahmood NA, Carmichael WW. Paralytic shellfish poisons produced by the freshwater cyanobacterium Aphanizomenon flosaquae NH-5. Toxicon. 1986;24:175–186. [PubMed]
91. Harada T, Oshima Y, Yasumoto T. Structure of two paralytic shellfish toxins, gonyautoxins V and VI, isolated from a tropical dinoflagellate Pyrodinium bahamense var. compressa. Agric Biol Chem. 1982;46:1861–1864.
92. Oshima Y, Hasegawa M, Yasumoto T, Hallegaeff G, Blackburn S. Dinoflagellate Gimnodium catenatum as the source of paralytic shellfishtoxins in Tasmanian shellfish. Toxicon. 1987;25:1105–1111. [PubMed]
93. Shimizu Y. In: Chemistry and Distribution of Deleterious Dinoflagellate Toxins. Faulkner D, Fenical W, editors. Plenum; New York, NY, USA: 1977. pp. 261–269.
94. Carmichael WW, Evans WR, Yin QQ, Bell P, Moczydlowski E. Evidence for paralytic shellfish poisons in the freshwater cyanobacterium Lyngbya wollei (Farlow ex Gomont) comb. nov. Appl Environ Microbiol. 1997;63:3104–3110. [PMC free article] [PubMed]
95. Humpage AR, Rositano JAB, Brown R, Baker P, Nicholson BC, Steffensen DA. Paralytic shellfish poisons from australian cyanobacterial blooms. Aust J Mar Freshwater Res. 1994;45:761–771.
96. Lagos N, Onodera H, Zagatto PA, Andrinolo D, Azevedo SM, Oshima Y. The first evidence of paralytic shellfish toxins in the fresh water cyanobacterium Cylindrospermopsis raciborskii, isolated from Brazil. Toxicon. 1999;37:1359–1373. [PubMed]
97. Ballot A, Fastner J, Wiedner C. Paralytic shellfish poisoning toxin-producing cyanobacterium Aphanizomenon gracile in northeast Germany. Appl Environ Microbiol. 2010;76:1173–1180. [PMC free article] [PubMed]
98. Llewellyn LE. Saxitoxin, a toxic marine natural product that targets a multitude of receptors. Nat Prod Rep. 2006;23:200–222. [PubMed]
99. Llewellyn LE, Negri AP, Doyle J, Baker PD, Beltran EC, Neilan BA. Radioreceptor assays for sensitive detection and quantitation of saxitoxin and its analogues from strains of the freshwater cyanobacterium, Anabaena circinalis. Environ Sci Technol. 2001;35:1445–1451. [PubMed]
100. Oshima Y. Postcolumn derivatization liquid chromatographic method for paralytic shellfish toxins. J AOAC Int. 1995;78:528–532.
101. Oshima Y, Blackburn S, Hallegraeff GM. Comparative study on paralytic shellfish toxin profiles of the dinoflagellate Gymnodinium catenatum from three different countries. Mar Biol. 1993;116:471–476.
102. Onodera H, Satake M, Oshima Y, Yasumoto T, Carmichael WW. New saxitoxin analogues from the freshwater filamentous cyanobacterium Lyngbya wollei. Nat Toxins. 1997;5:146–151. [PubMed]
103. Arakawa O, Nishio S, Noguchi T, Shida Y, Onoue Y. A new saxitoxin analogue from a xanthid crab Atergatis floridus. Toxicon. 1995;33:1577–1584. [PubMed]
104. Arakawa O, Noguchi T, Shida Y, Onoue Y. Occurrence of carbamoyl-N-hydroxy derivatives of saxitoxin and neosaxitoxin in a xanthid crab Zosimus aeneus. Toxicon. 1994;32:175–183. [PubMed]
105. Zaman L, Arakawa O, Shimosu A, Shida Y, Onoue Y. Occurrence of a methyl derivative of saxitoxin in Bangladeshi freshwater puffers. Toxicon. 1998;36:627–630. [PubMed]
106. Yotsu-Yamashita M, Kim YH, Dudley SC, Jr, Choudhary G, Pfahnl A, Oshima Y, Daly JW. The structure of zetekitoxin AB, a saxitoxin analog from the golden frog Atelopus zeteki: a potent sodium channel blocker. Proc Natl Acad Sci USA. 2004;101:4346–4351. [PubMed]
107. Kao CY. Paralytic shellfish poisoning. In: Falconer IR, editor. Algal Toxins in Seafood and Drinking Water. Academic Press; London, UK: 1993. pp. 75–86.
108. Kao CY, Levinson SR. Tetrodotoxin, Saxitoxin, and the Molecular Biology of the Sodium Channel. Vol. 479 The New York Academy of Science; New York, NY, USA: 1986.
109. Su Z, Sheets M, Ishida H, Li F, Barry WH. Saxitoxin blocks l-type ICa. J Pharmacol Exp Ther. 2004;308:324–329. [PubMed]
110. Wang J, Salata JJ, Bennett PB. Saxitoxin is a gating modifier of HERG K+ channels. J Gen Physiol. 2003;121:583–598. [PMC free article] [PubMed]
111. Halstead BW, Schantz EJ. Paralytic shellfish poisoning. WHO Offset Publ. 1984:1–59. [PubMed]
112. Evans MH. Mechanism of saxitoxin and tetrodotoxin poisoning. Br Med Bull. 1969;25:263–267. [PubMed]
113. Satin J, Kyle JW, Chen M, Bell P, Cribbs LL, Fozzard HA, Rogart RB. A mutant of TTX-resistant cardiac sodium channels with TTX-sensitive properties. Science. 1992;256:1202–1205. [PubMed]
114. Strichartz G. Structural determinabts of the affinity of saxitoxin for neuronal sodium channels. J Gen Physiol. 1984;84:281–305. [PMC free article] [PubMed]
115. Tikhonov DB, Zhorov BS. Modeling P-loops domain of sodium channel: homology with potassium channels and interaction with ligands. Biophys J. 2005;88:184–197. [PubMed]
116. Jiang Y, Lee A, Chen J, Cadene M, Chait BT, MacKinnon R. The open pore conformation of potassium channels. Nature. 2002;417:523–526. [PubMed]
117. Hall S, Strichartz G, Moczydlowski E, Ravindran A, Reichardt PB. The saxitoxins: sources, chemistry and pharmacology. In: Hall S, Reichardt PB, editors. Marine Toxins Origin, Structure and Pharmacology. American Chemical Society; Washington DC, USA: 1990. pp. 29–69.
118. Cembella AD, Shumway SE, Larocque R. Sequestering and putative biotransformation of paralytic shellfish toxins by the sea scallop Placopecten magellanicus -seasonal and spatial scales in natural populations. J Exp Mar Biol Ecol. 1994;180:1–22.
119. Cembella AD, Shumway SE, Lewis NI. Anatomical distribution and spatiotemporal variation in paralytic shellfish toxin composition in two bivalve species from the Gulf of Maine. J Shellfish Res. 1993;12:389–403.
120. Kellmann R, Mihali TK, Jeon YJ, Pickford R, Pomati F, Neilan BA. Biosynthetic intermediate analysis and functional homology reveal a saxitoxin gene cluster in cyanobacteria. Appl Environ Microbiol. 2008;74:4044–4053. [PMC free article] [PubMed]
121. Neuwald AF, Landsman D. GCN5-related histone N-acetyltransferases belong to a diverse superfamily that includes the yeast SPT10 protein. Trends Biochem Sci. 1997;22:154–155. [PubMed]
122. Hederstedt L, Rutberg L. Succinate dehydrogenase--a comparative review. Microbiol Rev. 1981;45:542–555. [PMC free article] [PubMed]
123. Mahmood NA, Carmichael WW. The pharmacology of anatoxin-a(s), a neurotoxin produced by the freshwater cyanobacterium Anabaena flos-aquae NRC 525–17. Toxicon. 1986;24:425–434. [PubMed]
124. Sako Y, Yoshida T, Uchida A, Arakawa O, Noguchi T, Ishida Y. Purification and characterization of a sulfotransferase specific to N-21 of saxitoxin and gonyautoxin 2+3 from the toxic dinoflagellate Gymnodinium catenatum (Dinophyceae) J Phycol. 2001;37:1044–1051.
125. Yoshida T, Sako Y, Uchida A, Kakutani T, Arakawa O, Noguchi T, Ishida Y. Purification and characterization of sulfotransferase specific to O-22 of 11-hydroxy saxitoxin from the toxic dinoflagellate Gymnodinium catenatum (dinophyceae) Fish Sci. 2002;68:634–642.
126. Schwedock JS, Long SR. Rhizobium meliloti genes involved in sulfate activation: the two copies of nodPQ and a new locus, sua. Genetics. 1992;132:899–909. [PubMed]
127. Akoh CC, Lee GC, Liaw YC, Huang TH, Shaw JF. GDSL family of serine esterases/lipases. Prog Lipid Res. 2004;43:534–552. [PubMed]
128. Pomati F, Rossetti C, Manarolla G, Burns BP, Neilan BA. Interactions between intracellular Na+ levels and saxitoxin production in Cylindrospermopsis raciborskii T3. Microbiology. 2004;150:455–461. [PubMed]
129. Brown MH, Paulsen IT, Skurray RA. The multidrug efflux protein NorM is a prototype of a new family of transporters. Mol Microbiol. 1999;31:394–395. [PubMed]
130. Anderson DM, Kulis DM, Sullivan JJ, Hall S, Lee C. Dynamics and physiology of saxitoxin production by the dinoflagellates Alexandrium spp. Mar Biol. 1990;104:511–524.
131. Dias E, Pereira P, Franca S. Production of paralytic shellfish toxins by Aphanizomenon sp. LMECYA 31 (cyanobacteria) J Phycol. 2002;38:705–712.
132. Gedaria AI, Luckas B, Reinhardt K, Azanza RV. Growth response and toxin concentration of cultured Pyrodinium bahamense var. compressum to varying salinity and temperature conditions. Toxicon. 2007;50:518–529. [PubMed]
133. Steed PM, Wanner BL. Use of the rep technique for allele replacement to construct mutants with deletions of the pstSCAB-phoU operon: evidence of a new role for the PhoU protein in the phosphate regulon. J Bacteriol. 1993;175:6797–6809. [PMC free article] [PubMed]
134. Ehria S, Ohmori M. NrrA, a nitrogen-responsive response regulator facilitates heterocyst development in the cyanobacterium Anabaena sp. strain PCC 7120. Mol Microbiol. 2006;59:1692–1703. [PubMed]
135. Forst S, Delgado J, Inouye M. Phosphorylation of OmpR by the Osmosensor EnvZ Modulates Expression of the ompF and ompC Genes in Escherichia coli. Proc Natl Acad Sci USA. 1989;86:6052–6056. [PubMed]
136. Mihali TK, Kellmann R, Neilan BA. Characterisation of the paralytic shellfish toxin biosynthesis gene clusters in Anabaena circinalis AWQC131C and Aphanizomenon sp. NH-5. BMC Biochem. 2009;10:8. [PMC free article] [PubMed]
137. Kellmann R, Mihali TK, Neilan BA. Identification of a saxitoxin biosynthesis gene with a history of frequent horizontal gene transfers. J Mol Evol. 2008;67:526–538. [PubMed]
138. Bourke ATC, Hawes RB, Neilson A, Stallman ND. An outbreak of hepato-enteritis (the Palm Island mystery disease) possibly caused by algal intoxication. Toxicon. 1983;21:45–48.
139. Byth S. Palm Island mystery disease. Med J Aust. 1980;2:40–42. [PubMed]
140. Saker ML, Thomas AD, Norton JH. Cattle mortality attributed to the toxic cyanobacterium Cylindrospermopsis raciborskii in an outback region of North Queensland. Environ Toxicol Water Qual. 1999;14:179–182.
141. Banker R, Carmeli S, Hadas O, Teltsch B, Porat R, Sukenik A. Identification of cylindrospermopsin in Aphanizomenon ovalisporum (Cyanophyceae) isolated from Lake Kinneret, Israel. J Phycol. 1997;33:613–616.
142. Harada K-I, Ohtani I, Iwamoto K, Suzuki M, Watanabe MF, Watanabe M, Terao K. Isolation of cylindrospermopsin from a cyanobacterium Umezakia natans and its screening method. Toxicon. 1994;32:73–84. [PubMed]
143. Li R, Carmichael WW, Brittain S, Eaglesham GK, Shaw GR, Liu Y, Watanabe MM. First report of the cyanotoxins cylindrospermopsin and deoxycylindrospermopsin from Raphidiopsis curvata (Cyanobacteria) J Phycol. 2001;37:1121–1126.
144. Li R, Carmichael WW, Brittain S, Eaglesham GK, Shaw GR, Mahakhant A, Noparatnaraporn N, Yongmanitchai W, Kaya K, Watanabe MM. Isolation and identification of the cyanotoxin cylindrospermopsin and deoxy-cylindrospermopsin from a Thailand strain of Cylindrospermopsis raciborskii (Cyanobacteria) Toxicon. 2001;39:973–980. [PubMed]
145. Preussel K, Stuken A, Wiedner C, Chorus I, Fastner J. First report on cylindrospermopsin producing Aphanizomenon flos-aquae (Cyanobacteria) isolated from two German lakes. Toxicon. 2006;47:156–162. [PubMed]
146. Schembri MA, Neilan BA, Saint CP. Identification of genes implicated in toxin production in the cyanobacterium Cylindrospermopsis raciborskii. Environ Toxicol. 2001;16:413–421. [PubMed]
147. Spoof L, Berg KA, Rapala J, Lahti K, Lepisto L, Metcalf JS, Codd GA, Meriluoto J. First observation of cylindrospermopsin in Anabaena lapponica isolated from the boreal environment (Finland) Environ Toxicol. 2006;21:552–560. [PubMed]
148. Seifert M, McGregor G, Eaglesham G, Wickramasinghe W, Shaw G. First evidence for the production of cylindrospermopsin and deoxy-cylindrospermopsin by the freshwater benthic cyanobacterium, Lyngbya wollei (Farlow ex Gomont) Speziale and Dyck. Harmful Algae. 2007;6:73–80.
149. Neilan BA, Saker ML, Fastner J, Torokne A, Burns BP. Phylogeography of the invasive cyanobacterium Cylindrospermopsis raciborskii. Mol Ecol. 2003;12:133–140. [PubMed]
150. Ohtani I, Moore RE, Runnegar MTC. Cylindrospermopsin: A potent hepatotoxin from the blue-green alga Cylindrospermopsis raciborskii. J Am Chem Soc. 1992;114:7941–7942.
151. Banker R, Carmeli S, Werman M, Teltsch B, Porat R, Sukenik A. Uracil Moiety is Required for Toxicity of the Cyanobacterial Hepatotoxin Cylindrospermopsin. J Toxicol Environ Health Part A. 2001;62:281–288. [PubMed]
152. Runnegar MT, Kong SM, Zhong YZ, Lu SC. Inhibition of reduced glutathione synthesis by cyanobacterial alkaloid cylindrospermopsin in cultured rat hepatocytes. Biochem Pharmacol. 1995;49:219–225. [PubMed]
153. Runnegar MT, Kong SM, Zhong YZ, Ge JL, Lu SC. The role of glutathione in the toxicity of a novel cyanobacterial alkaloid cylindrospermopsin in cultured rat hepatocytes. Biochem Biophys Res Commun. 1994;201:235–241. [PubMed]
154. Runnegar MT, Xie C, Snider BB, Wallace GA, Weinreb SM, Kuhlenkamp J. In vitro Hepatotoxicity of the Cyanobacterial Alkaloid Cylindrospermopsin and Related Synthetic Analogues. Toxicol Sci. 2002;67:81–87. [PubMed]
155. Kiss T, Vehovszky A, Hiripi L, Kovacs A, Voros L. Membrane effects of toxins isolated from a cyanobacterium, Cylindrospermopsis raciborskii, on identified molluscan neurones. Comp Biochem Physiol C: Toxicol Pharmacol. 2002;131:167–176. [PubMed]
156. Humpage AR, Fenech M, Thomas P, Falconer IR. Micronucleus induction and chromosome loss in transformed human white cells indicate clastogenic and aneugenic action of the cyanobacterial toxin, cylindrospermopsin. Mutat Res. 2000;472:155–161. [PubMed]
157. Froscio SM, Humpage AR, Burcham PC, Falconer IR. Cylindrospermopsin-induced protein synthesis inhibition and its dissociation from acute toxicity in mouse hepatocytes. Environ Toxicol Water Qual. 2003;18:243–251. [PubMed]
158. Norris RL, Eaglesham GK, Pierens P, Shaw GR, Smith MJ, Chiswell RK, Seawright AA, Moore MR. Deoxycylindrospermopsin, an analog of cylindrospermopsin from Cylindrospermopsis raciborskii. Environ Toxicol Water Qual. 1999;14:163–165.
159. Terao K, Ohmori S, Igarashi K, Ohtani I, Watanabe MF, Harada KI, Ito E, Watanabe M. Electron microscopic studies on experimental poisoning in mice induced by cylindrospermopsin isolated from blue-green alga Umezakia natans. Toxicon. 1994;32:833–843. [PubMed]
160. Wiegand C, Pflugmacher S. Ecotoxicological effects of selected cyanobacterial secondary metabolites: a short review. Toxicol Appl Pharmacol. 2005;203:201–218. [PubMed]
161. Mihali TK, Kellmann R, Muenchhoff J, Barrow KD, Neilan BA. Characterization of the gene cluster responsible for cylindrospermopsin biosynthesis. Appl Environ Microbiol. 2008;74:716–722. [PMC free article] [PubMed]
162. Burgoyne DL, Hemscheidt TK, Moore RE, Runnegar MT. Biosynthesis of cylindrospermopsin. J Org Chem. 2000;65:152–156. [PubMed]
163. Kellmann R, Mills T, Neilan BA. Functional modeling and phylogenetic distribution of putative cylindrospermopsin biosynthesis enzymes. J Mol Evol. 2006;62:267–280. [PubMed]
164. Shalev-Alon G, Sukenik A, Livnah O, Schwarz R, Kaplan A. A novel gene encoding amidinotransferase in the cylindrospermopsin producing cyanobacterium Aphanizomenon ovalisporum. FEMS Microbiol Lett. 2002;209:87–91. [PubMed]
165. Baldwin JE, Thomas RC, Kruse LI, Silberman L. Rules for ring closure: ring formation by conjugate addition of oxygen nucleophiles. J Org Chem. 1977;42:3846–3852.
166. Norris RL, Seawright AA, Shaw GR, Senogles P, Eaglesham GK, Smith MJ, Chiswell RK, Moore MR. Hepatic xenobiotic metabolism of cylindrospermopsin in vivo in the mouse. Toxicon. 2002;40:471–476. [PubMed]
167. Saker ML, Neilan BA, Griffiths DJ. Two morphological forms of cylindrospermopsis raciborskii (cyanobacteria) isolated from Solomon dam, palm island, Queensland. J Phycol. 1999;35:599–606.
168. Hansel A, Axelsson R, Lindberg P, Troshina OY, Wunschiers R, Lindblad P. Cloning and characterisation of a hyp gene cluster in the filamentous cyanobacterium Nostoc sp. strain PCC 73102. FEMS Microbiol Lett. 2001;201:59–64. [PubMed]
169. Tamagnini P, Axelsson R, Lindberg P, Oxelfelt F, Wünschiers R, Lindblad P. Hydrogenases and Hydrogen Metabolism of Cyanobacteria. Microbiol Mol Biol Rev. 2002;66:1–20. [PMC free article] [PubMed]

Articles from Marine Drugs are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)